Related Articles
Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids Corrigendum in /10.3892/ijo.2022.5397
RAF expression in human astrocytic tumors
Pan‑RAF inhibitor LY3009120 is highly synergistic with low‑dose cytarabine, but not azacitidine, in acute myeloid leukemia with <em>RAS</em> mutations
Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression.
COOPERATION BETWEEN MUTANT P53 AND THE RAS, RAF, ERBB-2 AND FGF-3 ONCOGENES FOR TRANSFORMATION OF MAMMARY EPITHELIAL-CELLS